| 4F 4PP oxalate |
selective 5-HT2A antagonist |
| BIO |
ATP-competitive GSK-3 inhibitor. |
| BWB70C |
selective inhibitor of 5-lipoxygenase |
| Canrenone |
aldosterone antagonist |
| DMPO |
neuroprotective agent, radical spin trap |
| Ezetimibe |
Inhibit cholesterol absorption in the small intestine |
| Flunixin meglumine |
non-steroidal anti-inflammatory |
| Fluvastatin |
HMG-CoA reductase inhibitor |
| Indirubin-3′-oxime |
GSK-3 inhibitor; also inhibits other protein kinases |
| Isoproterenol hydrocloride |
selective β-adrenoceptor agonist |
| Kenpaullone |
GSK-3 inhibitor; CDK inhibitor |
| Mevastatin |
HMG-CoA reductase inhibitor |
| n-methyl-metacryloyl-lupinine |
quinolizidine alkaloid extracted from plant |
| Phenoxybenzamine hydrochloride |
selective α-adrenoceptor blocking agent; calmodulin antagonist |
| SB 203580 |
selective inhibitor of p38 MAPK |
| SB 239063 |
potent, selective p38 MAPK inhibitor; orally active |
| SB 415286 |
competitive GSK-3 inhibitor. |
| Sotalol hydrochloride |
β-adrenoceptor agonist |
| Spermine tetrahydrochloride |
modulatory on the NMDA glutamate receptor |
| TCS 2002 |
GSK-3 inhibitor |
| Tolazoline hydrochloride |
non-selective competitive α-adrenoceptor antagonist |
